To what extent do oral contraceptives influence mood and affect?

Journal of Affective Disorders

Volumn 70, Issue 3, 2002, Pages 229-240

  Oinonen, Kirsten A ^a   Mazmanian, Dwight ^a  

^a LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Affect; Estrogen; Hormones; Mood; Oral contraceptives; Progesterone

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; TRIPHASIC CONTRACEPTIVE AGENT;

AFFECT; AFFECTIVE NEUROSIS; ANAMNESIS; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; DYSMENORRHEA; HORMONE DETERMINATION; HUMAN; MEDICAL RESEARCH; MEDLINE; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD; PREGNANCY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCINFO; REVIEW; RISK FACTOR; WEIGHT GAIN;

ADULT; AFFECT; CONTRACEPTIVES, ORAL; ESTROGENS; FEMALE; HUMANS; MOOD DISORDERS; PROGESTERONE; RISK FACTORS;

EID: 0036063732     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(01)00356-1     Document Type: Review

References (82)

1. Vitamin B6, depression and oral contraception
2. Comparative profiles of reliability, cycle control, and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol
3. Sex steroids, sexual behavior, and selection attention for erotic stimuli in women using oral contraceptives
4. Testosterone and sexual behavior in oral contraceptive users and nonusers: A prospective study
5. Mood changes during the menstrual cycle and their relation to the use of oral contraceptives
6. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms
7. The effects of oral contraceptives on well-being and sexuality
8. The effects of oral contraceptives on mood and sexuality: A comparison of triphasic and combined preparations
9. Prospective versus retrospective assessment of menstrual cycle symptoms and moods: Role of attitudes and beliefs
10. The influence of estrogen on monoamine oxidase activity
11. Neuroendocrinology
12. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high density lipoprotein particles
13. Mood changes and menstrual symptoms with different gestagen/estrogen combinations
14. Mental and sexual adjustment before and after six months use of an oral contraceptive
15. Use of monophasic, low-dose oral contraceptives in relation to mental functioning
16. The independence of positive and negative affect
17. Oral contraceptive medication in prevention of psychotic exacerbations associated with phases of the menstrual cycle
18. Oestrogen and mental state
19. Sex steroid control of mood, mental state, and memory
20. Incidence of depressive symptoms in users of the oral contraceptive
21. Cyclical variations in mood in normal women taking oral contraceptives
22. Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a 'real' difference?
23. Effect of oral contraceptives (Lyndiol) on rat brain gamma aminobutyric acid system
24. Improvement in symptoms of depression and in an index of life stressors accompany treatment of severe hypertriglyceridemia
25. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive
26. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms
27. Effect of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphates
28. The contraceptive pill, side effects and personality: Report of a controlled double blind trial
29. Patient satisfaction with a Levonorgestrel-releasing contraceptive implant: Reasons for and patterns of removal
30. Changes in psychological symptoms in women taking oral contraceptives
31. Depressive symptoms and oral contraceptives
32. Oral contraceptives, depression, and libido
33. The Royal College of General Practitioner's oral contraceptive study: Some recent observations
34. A twin study of the psychiatric side effects of oral contraceptives
35. Assessing subjective well-being in the old-old: The PANAS as a measure of orthogonal dimensions of positive and negative affect
36. Serum cholesterol levels in patients with generalized anxiety disorder (GAD) and with GAD and comorbid major depression
37. Types of oral contraceptives, depression, and premenstrual symptoms
38. History of depression as a risk factor for depression with oral contraceptives and discontinuance
39. An evaluation of depression as a side effect of oral contraceptives
40. Critical review of data supporting affective disorder caused by nonpsychotropic medication
41. An assessment of psychological state associated with the menstrual cycle in users of oral contraception
42. High-dose pyridoxine as an 'anti-stress' strategy
43. Mood fluctuations: Women versus men and menstrual versus other cycles
44. Effect of oral contraceptives on tryptophan and tyrosine availability: Evidence for a possible contribution to mental depression
45. Psychological aspects of oral contraceptives
46. Contraceptive pills and day-by-day feelings of well-being
47. A comparative analysis of three methods of contraception: Effects of blood glucose and serum lipid profiles
48. An investigation of mood states in women taking oral contraceptives
49. Psychiatric symptoms during the post-partum period as related to use of oral contraceptives
50. Side-effects of an oral contraceptive with particular attention to mental symptoms and sexual adaptation
51. Serum lipid concentrations in patients with major depressive disorder
52. Effects of oral contraceptives of affective fluctuations associated with the menstrual cycle
53. Can drugs cause depression? A review of the evidence
54. Premenstrual tension: A study using the Moos Menstrual Questionnaire
55. Possible antidepressant effect of oral contraceptives: Case report
56. Biological effects of eleven combined oral contraceptives on serum triglycerides, gamma-glutamyltransferase, alkaline phosphatase, bilirubin and other biochemical variables
57. Psychiatric aspects of oral contraceptive use
58. Hormones, mood, and cognitive functioning in postmenopausal women
59. The menstrual cycle: A double-blind study of symptoms, mood and behaviour, and biochemical variables using Enovid and placebo
60. Levonorgestrel capsule implants in the United States: A 5-year study
61. Oral contraceptives and depression: Impact, prevalence, and cause
62. Progesterone alters GABA and glutamate responsiveness: A possible mechanism for its anxiolytic action
63. Estrogen, progestogens and cardiovascular risk
64. Relations of trait depression and anxiety to low lipid and lipoprotein concentrations in healthy young adult women
65. Alcohol use, negative mood states, and menstrual cycle phases
66. Biological processes in depression: An updated review and integration
67. Contraceptive failure in the United States: A critical review of the literature
68. Stress, serotonergic function, and mood in users of oral contraceptives
69. Oral contraception and serious psychiatric illness: Absence of an association
70. Relationship between premenstrual symptoms and oral contraceptive use: A controlled study
71. Mood, sexuality, oral contraceptives and the menstrual cycle
72. Toward a consensual structure of mood
73. Effects of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters
74. Daily self-reports on activities, life events, moods, and somatic changes during the menstrual cycle
75. Tryptophan, depression and steroidal contraception